(Q34328170)

1 August 2017

1 reference

title

Epstein-Barr virus infection and human malignancies (English)

1 reference

1 August 2017

0 references

Henri-Jacques Delecluse

series ordinal

3

1 reference

1 August 2017

G Niedobitek

1

1 reference

PubMed ID

11488990

1 August 2017

N Meru

series ordinal

2

1 reference

1 August 2017

1 June 2001

1 reference

International Journal of Experimental Pathology

1 August 2017

1 reference

1 August 2017

82

1 reference

1 August 2017

3

1 reference

1 August 2017

149-170

1 reference

Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction

1 August 2017

1 reference

12 December 2020

The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation

1 reference

12 December 2020

An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation

1 reference

12 December 2020

Regulated genomic instability and neoplasia in the lymphoid lineage

1 reference

12 December 2020

The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining

1 reference

12 December 2020

Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization

1 reference

12 December 2020

trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.

1 reference

12 December 2020

Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

1 reference

12 December 2020

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

1 reference

12 December 2020

Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma

1 reference

12 December 2020

Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.

1 reference

12 December 2020

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

1 reference

12 December 2020

The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization

1 reference

12 December 2020

Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

1 reference

12 December 2020

RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination

1 reference

12 December 2020

Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element

1 reference

12 December 2020

1 reference

12 December 2020

Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma

1 reference

12 December 2020

Infection of human thymocytes by Epstein-Barr virus

1 reference

12 December 2020

Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation

1 reference

12 December 2020

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells

1 reference

12 December 2020

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

1 reference

12 December 2020

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group

1 reference

12 December 2020

The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.

1 reference

12 December 2020

Epstein-Barr virus in inflammatory diseases of the liver and liver allografts: an in situ hybridization study

1 reference

12 December 2020

Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.

1 reference

12 December 2020

Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV

1 reference

12 December 2020

Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease

1 reference

12 December 2020

Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA.

1 reference

12 December 2020

Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS.

1 reference

12 December 2020

The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation.

1 reference

12 December 2020

Epstein-Barr virus-associated primary malignant lymphomas of the pleural cavity occurring in longstanding pleural chronic inflammation

1 reference

12 December 2020

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

12 December 2020

Epstein-Barr virus in epithelial cell tumors: a breast cancer study.

1 reference

12 December 2020

Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders

1 reference

12 December 2020

The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues.

1 reference

12 December 2020

Post-transplant lymphoproliferative disorders with genetic abnormalities commonly found in malignant tumours

1 reference

12 December 2020

The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.

1 reference

12 December 2020

Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells.

1 reference

12 December 2020

Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa

1 reference

12 December 2020

Absence of Epstein-Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping, in situ hybridization and polymerase chain reaction

1 reference

12 December 2020

Patterns of Epstein-Barr virus infection in non-Hodgkin's lymphomas

1 reference

12 December 2020

Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types

1 reference

12 December 2020

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

12 December 2020

BCL-6 protein is expressed in germinal-center B cells

1 reference

12 December 2020

Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV

1 reference

12 December 2020

Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.

1 reference

12 December 2020

Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease

1 reference

12 December 2020

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma

1 reference

12 December 2020

Increased number of Epstein-Barr virus latently infected B-cells in T-cell non-Hodgkin's lymphoma tissues

1 reference

12 December 2020

Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice

1 reference

12 December 2020

Rare occurrence of classical Hodgkin's disease as a T cell lymphoma

1 reference

12 December 2020

Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.

1 reference

12 December 2020

Radiation-induced expression of functional Fas ligand in EBV-positive human nasopharyngeal carcinoma cells.

1 reference

12 December 2020

Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.

1 reference

12 December 2020

Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene

1 reference

12 December 2020

Epstein-Barr virus (EBV) in infectious mononucleosis: detection of the virus in tonsillar B lymphocytes but not in desquamated oropharyngeal epithelial cells

1 reference

12 December 2020

Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.

1 reference

12 December 2020

Hodgkin's disease and peripheral T-cell lymphoma: composite lymphoma with evidence of Epstein-Barr virus infection

1 reference

12 December 2020

Three classes of cell surface receptors for alphaherpesvirus entry

1 reference

12 December 2020

Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands

1 reference

12 December 2020

High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese

1 reference

12 December 2020

Clinical syndromes associated with EB virus infection

1 reference

12 December 2020

EB viral genomes in epithelial nasopharyngeal carcinoma cells

1 reference

12 December 2020

Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference

1 reference

12 December 2020

Immunomodulation of tumor growth

1 reference

12 December 2020

Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution

1 reference

12 December 2020

Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity

1 reference

12 December 2020

Replication of Epstein–Barr virus in human epithelial cells infected in vitro

1 reference

12 December 2020

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

1 reference

12 December 2020

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

1 reference

12 December 2020

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2

1 reference

12 December 2020

Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2)

1 reference

12 December 2020

Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region

1 reference

12 December 2020

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

1 reference

12 December 2020

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

1 reference

12 December 2020

Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis

1 reference

12 December 2020

Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells

1 reference

12 December 2020

The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction

1 reference

12 December 2020

Disappearance of the Epstein-Barr virus in a relapse of Hodgkin's disease

1 reference

12 December 2020

Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21.

1 reference

12 December 2020

Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus

1 reference

12 December 2020

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

1 reference

12 December 2020

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

1 reference

12 December 2020

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

1 reference

12 December 2020

Epstein-Barr virus infection and malignant lymphomas in liver transplant recipients

1 reference

12 December 2020

The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma

1 reference

12 December 2020

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade

1 reference

12 December 2020

Intraclonal molecular heterogeneity suggests a hierarchy of pathogenetic events in Burkitt's lymphoma

1 reference

12 December 2020

Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect

1 reference

12 December 2020

Epstein-Barr virus in B-cell lymphomas associated with chronic suppurative inflammation

1 reference

12 December 2020

Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells

1 reference

12 December 2020

Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease

1 reference

12 December 2020

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

1 reference

12 December 2020

Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells

1 reference

12 December 2020

Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).

1 reference

12 December 2020

CD40 and CD70 co-stimulate a potent in vivo antitumor T cell response.

1 reference

12 December 2020

Antigen presenting phenotype of Hodgkin Reed-Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on epstein-barr virus-specific cytotoxic T-cell recognition

1 reference

12 December 2020

Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis

1 reference

12 December 2020

Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of epithelial cells.

1 reference

12 December 2020

Frequent detection of Epstein-Barr virus-infected B cells in peripheral T-cell lymphomas

1 reference

12 December 2020

Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.

1 reference

12 December 2020

Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency

1 reference

12 December 2020

EBV persistence in memory B cells in vivo.

1 reference

12 December 2020

An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator

1 reference

12 December 2020

Epstein-Barr virus in AIDS-related primary central nervous system lymphoma

1 reference

12 December 2020

The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation

1 reference

12 December 2020

Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus.

1 reference

12 December 2020

Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase

1 reference

12 December 2020

Epstein-Barr virus infection and replication in a human epithelial cell system

1 reference

12 December 2020

Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2

1 reference

12 December 2020

Infection of the HTLV-I-harbouring T-lymphoblastoid line MT-2 by Epstein-Barr virus

1 reference

12 December 2020

Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue

1 reference

12 December 2020

Heterogeneity among human nasopharyngeal carcinoma cell lines for inflammatory cytokines mRNA expression levels

1 reference

12 December 2020

Characterization of an Epstein-Barr virus receptor on human epithelial cells

1 reference

12 December 2020

Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro

1 reference

12 December 2020

Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype

1 reference

12 December 2020

Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis

1 reference

12 December 2020

Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 alpha

1 reference

12 December 2020

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells

1 reference

12 December 2020

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections

1 reference

12 December 2020

Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus

1 reference

12 December 2020

Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity

1 reference

12 December 2020

Identification of Epstein-Barr virus-infected cells in tonsils of acute infectious mononucleosis by in situ hybridization

1 reference

12 December 2020

Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization.

1 reference

12 December 2020

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

1 reference

12 December 2020

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

1 reference

12 December 2020

Epstein-Barr virus in pyothorax-associated pleural lymphoma

1 reference

12 December 2020

Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency

1 reference

12 December 2020

Mutants of Epstein-Barr virus with a selective marker disrupting the TP gene transform B cells and replicate normally in culture

1 reference

12 December 2020

High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas

1 reference

12 December 2020

Epstein-Barr virus persistence and virus-associated tumours

1 reference

12 December 2020

Human papillomavirus types 11 and 16 detected in nasopharyngeal carcinomas by the polymerase chain reaction.

1 reference

12 December 2020

The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: two new developments in the EBV field

1 reference

12 December 2020

Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue.

1 reference

12 December 2020

Functionally active Epstein-Barr virus-transformed follicular dendritic cell-like cell lines

1 reference

12 December 2020

Lymphoepithelioma-like carcinoma of the breast

1 reference

12 December 2020

Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation

1 reference

12 December 2020

Modulation of vimentin, the CD40 activation antigen and Burkitt's lymphoma antigen (CD77) by the Epstein-Barr virus nuclear antigen EBNA-4.

1 reference

12 December 2020

Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa

1 reference

12 December 2020

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

1 reference

12 December 2020

The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element

1 reference

12 December 2020

Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions

1 reference

12 December 2020

Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.

1 reference

12 December 2020

Interleukin-10 abrogates the inhibition of Epstein-Barr virus-induced B-cell transformation by memory T-cell responses.

1 reference

12 December 2020

Immune escape mechanisms in Hodgkin's disease

1 reference

12 December 2020

Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma

1 reference

12 December 2020

Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: opposite effects of CD95 and CD40 stimulation

1 reference

12 December 2020

Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine

1 reference

12 December 2020

Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters

1 reference

12 December 2020

Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus

1 reference

12 December 2020

Staining of interleukin-10 predicts clinical outcome in patients with nasopharyngeal carcinoma.

1 reference

12 December 2020

Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression

1 reference

12 December 2020

Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells

1 reference

12 December 2020

Mapping EBNA-1 domains involved in binding to metaphase chromosomes.

1 reference

12 December 2020

The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2.

1 reference

12 December 2020

Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase.

1 reference

12 December 2020

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

1 reference

12 December 2020

Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription

1 reference

12 December 2020

High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma

1 reference

12 December 2020

Elevated serum levels of transforming growth factor beta1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients.

1 reference

12 December 2020

Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma

1 reference

12 December 2020

Activation of the small GTPase Cdc42 by the inflammatory cytokines TNF(alpha) and IL-1, and by the Epstein-Barr virus transforming protein LMP1.

1 reference

12 December 2020

Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus

1 reference

12 December 2020

Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses

1 reference

12 December 2020

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

1 reference

12 December 2020

THE AFRICAN LYMPHOMA: PRELIMINARY OBSERVATIONS ON RESPONSE TO THERAPY.

1 reference

12 December 2020

Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.

1 reference

12 December 2020

Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders

1 reference

12 December 2020

Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells

1 reference

12 December 2020

Signal transduction. Notch takes a short cut.

1 reference

12 December 2020

Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines

1 reference

12 December 2020

Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters

1 reference

12 December 2020

Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2

1 reference

12 December 2020

Non-Hodgkin's lymphoma, coeliac disease, and Epstein-Barr virus: a study of 13 cases of enteropathy-associated T- and B-cell lymphoma.

1 reference

12 December 2020

Molecular pathogenesis of AIDS-related lymphomas.

1 reference

12 December 2020

Hodgkin's disease after transplantation

1 reference

12 December 2020

In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma

1 reference

12 December 2020

The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa)

1 reference

12 December 2020

Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients

1 reference

12 December 2020

Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies.

1 reference

12 December 2020

Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma

1 reference

12 December 2020

Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma

1 reference

12 December 2020

The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy

1 reference

12 December 2020

EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency

1 reference

12 December 2020

The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell

1 reference

12 December 2020

Expression of the recombination activating genes (RAG1 and RAG2) is not detectable in Epstein-Barr virus-associated human lymphomas

1 reference

12 December 2020

Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease

1 reference

12 December 2020

Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens.

1 reference

12 December 2020

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

1 reference

12 December 2020

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein

1 reference

12 December 2020

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

1 reference

12 December 2020

The latent membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell immortalization

1 reference

12 December 2020

Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma.

1 reference

12 December 2020

Epstein-Barr virus and gastric carcinoma

1 reference

12 December 2020

EBV infection of T cells: potential role in malignant transformation

1 reference

12 December 2020

Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma

1 reference

12 December 2020

CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator.

1 reference

12 December 2020

Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: implications for immune-mediated therapy of EBV+ Hodgkin's disease

1 reference

12 December 2020

Strict lymphotropism of Epstein-Barr virus during acute infectious mononucleosis in nonimmunocompromised individuals

1 reference

12 December 2020

Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response

1 reference

12 December 2020

Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors

1 reference

12 December 2020

Interleukin-10 expression and cytotoxic-T-cell response in Epstein-Barr-virus-associated nasopharyngeal carcinoma

1 reference

12 December 2020

Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain

1 reference

12 December 2020

The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B

1 reference

12 December 2020

Epstein-Barr virus and CD30+ malignant lymphomas.

1 reference

12 December 2020

Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States.

1 reference

12 December 2020

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells

1 reference

12 December 2020

Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.

1 reference

12 December 2020

Posttransplantation lymphoproliferative disorders

1 reference

12 December 2020

Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma.

1 reference

12 December 2020

Characterization of seven newly established nasopharyngeal carcinoma cell lines.

1 reference

12 December 2020

Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas.

1 reference

12 December 2020

Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B.

1 reference

12 December 2020

Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease

1 reference

12 December 2020

The clonal progression in the neoplastic process of nasopharyngeal carcinoma

1 reference

12 December 2020

Inflammatory pseudotumor of the liver. Evidence for follicular dendritic reticulum cell proliferation associated with clonal Epstein-Barr virus

1 reference

12 December 2020

Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice

1 reference

12 December 2020

Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction

1 reference

12 December 2020

Epstein-Barr virus and the B cell: that's all it takes

1 reference

12 December 2020

Is EBV persistence in vivo a model for B cell homeostasis?

1 reference

12 December 2020

Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells

1 reference

12 December 2020

Nasopharyngeal cancer in a low-risk population: defining risk factors by histological type

1 reference

12 December 2020

Regulation of Epstein-Barr virus latency by latent membrane protein 2.

1 reference

12 December 2020

10.1046/J.1365-2613.2001.00190.X

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11488990